(Q46159176)

20 December 2017

title

Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation (English)

1 reference

20 December 2017

1 reference

Ryan Carr

1

1 reference

20 December 2017

Spero R Cataland

series ordinal

2

1 reference

20 December 2017

publication date

15 November 2012

1 reference

20 December 2017

published in

Annals of Hematology

1 reference

20 December 2017

volume

92

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

845-846

1 reference

20 December 2017

Atypical hemolytic-uremic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Eculizumab for congenital atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

New insights into postrenal transplant hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1622-Z

10.1007/S00277-012-1622-Z

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017